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Purpose: To test the feasibility of altering the phenotype of umbilical cord blood mesenchymal stem cells (UCB MSCs)
toward that of human corneal endothelial cells (HCEC) and to determine whether UCB MSCs can “home” to sites of
corneal endothelial cell injury using an ex vivo corneal wound model.
Methods: RNA was isolated and purified from UCB MSCs and HCECs. Baseline information regarding the relative gene
expression of UCB MSCs and HCEC was obtained by microarray analysis. Quantitative real-time PCR (q-PCR) verified
the microarray findings for a subset of genes. The ability of different culture media to direct UCB MSCs toward a more
HCEC-like phenotype was tested in both tissue culture and ex vivo corneal endothelial wound models using three different
media: MSC basal medium (MSCBM), a basal medium used to culture lens epithelial cells (LECBM), or lens epithelial
cell-conditioned medium (LECCM). Morphology of the MSCs was observed by phase-contrast microscopy or by light
microscopic observation of crystal violet-stained cells. Immunolocalization of the junction-associated proteins, zonula
occludins-1 (ZO1) and N-cadherin, was visualized by fluorescence confocal microscopy. Formation of cell-cell junctions
was tested by treatment with the calcium chelator, EGTA. A second microarray analysis compared gene expression
between UCB MSCs grown in LECBM and LECCM to identify changes induced by the lens epithelial cell-conditioned
culture  medium.  The  ability  of  UCB  MSCs  to  “home”  to  areas  of  endothelial  injury  was  determined  using  ZO1
immunolocalization patterns in ex vivo corneal endothelial wounds.
Results: Baseline microarray analysis provided information regarding relative gene expression in UCB MSCs and HCECs.
MSCs attached to damaged, but not intact, corneal endothelium in ex vivo corneal wounds. The morphology of MSCs
was consistently altered when cells were grown in the presence of LECCM. In tissue culture and in ex vivo corneal wounds,
UCB MSC treated with LECCM were elongated and formed parallel sheets of closely apposed cells. In both tissue culture
and ex vivo corneal endothelial wounds, ZO1 and N-cadherin localized mainly to the cytoplasm of UCB MSCs in the
presence of MSCBM. However, both proteins localized to cell borders when UCB MSCs were grown in either LECBM
or LECCM. This localization was lost when extracellular calcium levels were reduced by treatment with EGTA. A second
microarray analysis showed that, when UCB MSCs were grown in LECCM instead of LECBM, the relative expression
of a subset of genes markedly differed, suggestive of a more HCEC-like phenotype.
Conclusions: Results indicate that UCB MSCs are able to “home” to areas of injured corneal endothelium and that the
phenotype of UCB MSCs can be altered toward that of HCEC-like cells. Further study is needed to identify the specific
microenvironmental conditions that would permit tissue engineering of UCB MSCs to replace damaged or diseased corneal
endothelium.
Restoration of clear vision that was lost due to injury or
disease  of  the  corneal  endothelium  requires  either  full-
thickness corneal transplantation or endothelial keratoplasty.
Researchers  are  currently  seeking  alternative  methods  to
restore healthy corneal endothelium, since corneas that are
Correspondence  to:  Nancy  C.  Joyce,  Ph.D.,  Emeritus  Senior
Scientist,  Schepens  Eye  Research  Institute,  20  Staniford  Street,
Boston, MA, 02114; email: nancy.joyce@schepens.harvard.edu or
NancyJoyce85@gmail.com
Dr.  Biagio  Saitta  is  presently  at  the  Department  of  Biomedical
Sciences, Cedars-Sinai Medical Center, Los Angeles, CA
considered to be acceptable for transplantation are becoming
less available worldwide [1-3]. Tissue bioengineering is an
exciting new approach to develop treatments for patients who
have lost visual acuity due to corneal endothelial cell injury
or disease. One method being investigated is to use cultured
donor human corneal endothelial cells (HCEC) to develop
bioengineered constructs. HCEC have a finite, donor age-
dependent ability to divide [4,5] and the number of times
HCECs can be passaged in culture limits the available number
of healthy cells for use in these constructs. Researchers are
also developing methods to selectively isolate HCEC with
characteristics of “young” cells for use in bioengineering [6],
while others are testing the use of immortalized HCEC for
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547longer-term  cultivation  [7],  although  use  of  immortalized
HCEC  for  human  transplant  is  problematic.  Another
possibility  is  to  identify,  isolate  and  culture  corneal
endothelial stem cells; however, only preliminary evidence
currently exists to suggest that there is a population of adult
stem cells that gives rise to corneal endothelium [8,9].
The current studies explore the feasibility of altering the
phenotype  of  non-hematopoietic  umbilical  cord  blood
mesenchymal stem/stromal cells (UCB MSCs) toward that of
HCEC-like cells. This idea is based on the fact that, during
eye development in many species, including humans, corneal
endothelial  cells  differentiate  from  neural  crest-derived
periocular  mesenchymal  cells  that  migrate  between  the
surface  epithelium  and  lens  placode  [10-15].  Those
mesenchymal  cells  closest  to  the  anterior  surface  of  the
developing  lens  become  flattened  and  establish  cell-cell
contacts,  forming  the  corneal  endothelium.  The  origin  of
human  corneal  endothelium  from  neural  crest-derived
mesenchymal  cells  is  supported  not  only  by  morphologic
studies, but also by immunohistochemical evidence indicating
that  both  cell  types  express  several  neural  crest  proteins,
including neuron-specific enolase [16-18], S-100 [19], neural
cell adhesion molecule (N-CAM) [16], N-cadherin [20], and
vimentin [17,21,22]. Interestingly, during early stages of eye
development,  differentiation  of  neural  crest-derived
mesenchymal cells to form corneal endothelium is strongly
influenced by inductive signals produced by lens epithelial
cells [20-25].
MSCs  offer  great  promise  for  use  in  cell-based
therapeutic  strategies,  primarily  because  of  their  intrinsic
ability to self-renew and their potential to differentiate into
several different cell types [26,27]. MSCs have been isolated
from several tissues, including bone marrow [28], adipose
tissue [29], synovium [30], skeletal muscle [31], deciduous
dental pulp [32], Wharton’s jelly [33], umbilical cord [34],
and  umbilical  cord  blood  [35].  MSCs  isolated  from  bone
marrow and umbilical cord blood have been the most widely
studied. UCB MSCs, isolated following full-term deliveries,
exhibit stem cell-like plasticity and tend to “home” to and
attach to areas of injury where they can differentiate into
different  cell  types  depending  on  the  specific
microenvironment [27]. The current studies also explore the
ability of UCB MSCs to “home” to areas of endothelial cell
injury using an ex vivo corneal endothelial wound model, as
well as test the ability of three different culture media to alter
the UCB MSC phenotype toward that of HCEC-like cells.
UCB MSCs have several advantages over other stem cell
sources for the following reasons: 1) Their relative plasticity
overcomes the moral and ethical issues of using embryonic
stem  cells;  2)  MSCs  from  umbilical  cord  blood  are  a
“younger” type of stem cell than other sources, such as bone
marrow, which can exhibit a decrease in both proliferative and
differentiation capacity with donor age; and 3) UCB appears
to contain populations of MSCs with broader differentiation
potential [36] compared to adult mesenchymal stem cells,
such as cells isolated from bone marrow. Prior studies by
members  of  our  group  [37]  demonstrated  phenotypic
heterogeneity in MSCs isolated from umbilical cord blood.
Based on this work, two UCB MSC clones were chosen for
the current study and designated UCB1 and UCB4 MSCs.
UCB1 cells are from the same clone as described previously
[37]. These cells are small, elongated, and exhibit relatively
fast population doubling times. The characteristics of UCB4
MSCs were not described previously; however, the phenotype
of these cells is very similar to that of UCB2 cells, which have
been described [37]. These cells are larger and more flattened
than UCB1 cells. They grow in focal patches and exhibit
slower population doubling times than UCB1 MSCs. Both
populations  of  cells  express  the  following  MSC  surface
markers: CD29 (integrin, beta-1), CD44 (CD44 molecule,
Indian  blood  group),  CD73  (5’-nucleotidase,  ecto),  CD90
(THY1 cell surface antigen), and CD105 (endoglin), as well
as COL1A1 (collagen type 1, alpha 1) and FN1 (fibronectin).
Neither  population  exhibits  the  hematopoietic  markers:
CD11b (integrin, alpha M), CD34 (CD34 molecule), CD35
(CR1  complement  component  (3b/4b)  receptor-1),  or  the
endothelial  cell  marker,  CD31  (platelet/endothelial  cell
adhesion  molecule-1).  Both  populations  are  capable  of
adipogenic,  osteogenic,  and  chondrogenic  differentiation,
although they appear to exhibit quantitative differences in
differentiation potential [37].
The current studies used microarray analysis to obtain
baseline information regarding the relative gene expression of
UCB MSCs compared with HCEC. A tissue culture model
and an ex vivo corneal endothelial wound model were used to
compare  the  ability  of  three  culture  media  to  alter  the
phenotype of UCB MSCs toward more HCEC-like cells. The
ex vivo wound model was also used to test the ability of UCB
MSCs  to  ‘home”  to  damaged  endothelium.  A  second
microarray analysis identified changes in the expression of
UCB MSC genes toward that of HCEC-like cells following
differential medium incubation.
METHODS
Umbilical cord blood samples: De-identified umbilical cord
blood (UCB) samples were harvested at birth from full-term
deliveries,  after  informed  parental  consent,  under  an
Institutional Review Board-approved protocol to the New
Jersey Cord Blood Bank located within Coriell Institute for
Medical  Research,  Camden,  NJ.  After  removal  of  the
placenta,  blood  was  collected  within  the  first  10  min  of
delivery and drained from the distal end of the umbilical vein
by  gravity  into  a  plastic  bag  containing  25  ml  of  citrate
phosphate  dextrose  anticoagulant  solution  (Medsep
Corporation, Covina, CA). These anonymous UCB samples
were stored at room temperature and units considered non-
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548bankable due to low volume were processed within 24 h of
delivery.
Umbilical cord blood mesenchymal stem cells (UCB MSCs):
MSCs were isolated from umbilical cord blood and individual
clones  were  cultured  and  characterized  as  described
previously  [37].  Some  UCB1  MSCs  were  labeled  by
transduction with a self-inactivating (SIN) lentivirus vector
expressing  enhanced  Green  Fluorescent  Protein  (E-GFP)
[38]  and  FACS-sorted  to  enrich  for  the  GFP-labeled
population.  Under  an  appropriate  Materials  Transfer
Agreement  and  written  approval  from  the  Schepens
Institutional  Review  Board,  cells  were  used  for  further
studies. Clones designated as UCB1 and UCB4 were used for
the  current  studies  and  were  carefully  thawed  and  then
cultured according to published protocols [37]. Briefly, cells
were grown at 37 °C in a humidified atmosphere containing
5% CO2 in culture medium, designated for these studies as
MSC basal medium (MSCBM). This medium consisted of
Dulbecco’s  modified  Eagle’s  Medium  with  low  glucose
(Invitrogen  Life  Technologies,  Carlsbad,  CA),  10%  fetal
bovine serum (FBS; Sigma-Aldrich, St. Louis, MO), and 1%
penicillin-streptomycin (Invitrogen). Cells were cultured for
3 weeks to obtain sufficient cells for experimental use, while
preventing senescence due to multiple passages.
In  some  experiments,  UCB  MSCs  were  seeded  onto
Permanox tissue culture slides (Sigma-Aldrich) and grown in
culture medium until cells filled the slide area. Cells were
either directly visualized by phase-contrast microscopy or
fixed for 10 min in ice-cold 100% methanol, stained for 10
min with 0.5% crystal violet in methanol at room temperature,
and washed with water before visualization with a Nikon
Eclipse Inverted Microscope TS100 (Nikon Instruments Inc.,
Melville, NY). In other experiments, UCB MSCs were grown
in  various  culture  media  as  described  and  then  directly
processed  for  immunocytochemical  localization  studies  or
were removed from the culture plate and either processed for
microarray analysis or used in ex vivo corneal endothelial
wound studies (see below).
Human corneas: Human corneas were obtained through the
National Disease Research Interchange (NDRI, Philadelphia,
PA). Handling of donor information by the source eye bank,
NDRI,  and  this  laboratory  adhered  to  the  tenets  of  the
Declaration of Helsinki in protecting donor confidentiality.
All corneas were preserved in Optisol-GS (Bausch & Lomb,
Rochester,  NY)  at  4  °C.  Exclusion  criteria  have  been
previously published [5]. Briefly, all corneas used in these
studies were considered unsuitable for transplant, but retained
endothelium  with  a  density  of  at  least  2,000  cells/mm2.
Corneas were not accepted for study if donor blood samples
were  not  available  for  serology  testing,  if  detects  were
microscopically visible in any layer of the cornea, or if gutatta
were visible. Corneas were rejected if the time between death
and  preservation  was  greater  than  24  h,  if  the  donor  had
diabetes, glaucoma, sepsis, or ocular infection, or had been on
large doses of chemotherapeutic agents. Some corneas were
used  for  ex  vivo  corneal  endothelial  wound  studies  (see
below). For other studies, the endothelium and Descemet’s
membrane  were  carefully  dissected  from  the  corneas  and
HCEC were cultured as previously described [5,39]. Briefly,
under  a  dissecting  microscope,  the  endothelium  with
Descemet’s  membrane  was  carefully  dissected  from  the
cornea  in  small  strips.  Endothelial  pieces  were  incubated
overnight  in  culture  medium  containing  8%  fetal  bovine
serum to stabilize the cells. The strips were then placed in
0.02%  ethylenediaminetetraacetic  acid  (EDTA)  in  Hank’s
balanced salt solution at pH 7.4 and incubated 1 h at 37 °C to
loosen  cell-cell  junctions.  Following  incubation,  junctions
were disrupted by moving the tissue and medium multiple
times through the narrow opening of a flame-polished glass
pipette.  Cells  were  then  collected  by  centrifugation  and
cultured  at  37  °C  in  a  5%  carbon  dioxide,  humidified
atmosphere.
RNA isolation: Total RNA was isolated and purified from
cultured UCB MSCs and HCECs using an RNAeasy Mini Kit
(Qiagen, Valencia, CA). Following quantification of the RNA
using  a  Nanodrop  spectrophotometer  (Thermo  Fisher
Scientific,  Wilmington,  DE),  samples  were  frozen  until
further analysis.
Microarray  analysis:  Microarray  experiments  were
conducted  on  a  GeneChip  Human  Exon  1.0  ST  platform
(Affymetrix, Santa Clara, CA). Hybridization and scanning
were performed according to manufacturer’s protocols in the
Nucleotide and Protein Core Facility at Children’s Hospital
of Philadelphia, Philadelphia, PA, similar to our previous
studies [37]. Data processing and analysis were performed
within the R statistical environment. Affymetrix probes were
re-grouped into unique Entrez gene IDs using custom library
files downloaded from the BRAINARRAY database. Raw
data were normalized and summarized by the RMA (Robust
Multichip Averaging) method to generate an N*M matrix,
where N is the number of unique Entrez genes and M is the
number  of  samples.  The  normalized  data  were  log2-
transformed  for  statistical  analysis.  The  hierarchical
clustering  and  heat  map  plots  were  generated  by  the  R
hclust and heatmap functions, respectively.
Quantitative real-time PCR: For quantitative real-time PCR
(qPCR) analysis, cDNA was synthesized from total RNA
using  Super  Script  III  (Invitrogen).  Primers  specific  for
NCAM1, TFAP2B (transcription factor activating enhancer
binding  protein  2-beta),  CDK15  (cyclin-dependent
kinase-15), MEIS1 (meis homeobox-1), COL8A1 (collagen
type VIII alpha-1), THY1 (thy1 cell surface antigen), CDH2
(cadherin-2, type 1 N-cadherin), and TJP1 (tight junction
protein-1 ZO1) were used for analysis and are listed in Table
1.  The  primers  were  designed  with  Primer  Express  1.5a
software (Invitrogen). A Step One Real Time PCR System
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549(Invitrogen) was used. The PCR reaction was performed in a
25  µl  final  volume,  which  contained  SYBR  Green  PCR
Master Mix, 6 µM each of human specific primers, and cDNA.
Thermal cycling was performed for 40 cycles at 95 °C for 15
s, 60 °C for 1 min and the amount of PCR product was
estimated  using  a  relative  standard  curve  quantification
method. Melting curve analysis controlled the quality of the
PCR products. All samples were analyzed in triplicate and
results were normalized to the housekeeping gene, GAPDH
(glyceraldehyde-3-phosphate dehydrogenase). The data were
expressed as mean±SD and shown relative to the highest value
(0 to 1). Statistical analysis was performed with an unpaired
student t-test and differences with a probability (p) value
≤0.05 was considered statistically significant.
Ex vivo corneal endothelial wound models: Two models using
human donor corneas were employed in the current studies.
One model consisted of a mechanical scrape wound made in
the  endothelium  in  an  X-shaped  pattern  using  a  capsule
polisher (Alcon, Fort Worth, TX). In this model, endothelial
cells were removed from the wounded area without damage
to  the  underlying  Descemet’s  membrane.  An  endothelial
crush  wound  model  was  prepared  by  lightly  scraping  the
endothelial  surface  with  the  capsule  polisher,  leaving  the
damaged  cells  on  the  surface  of  Descemet’s  membrane.
Depending on the needs of the experiment, GFP-labeled or
unlabeled UCB1 MSCs were grown to confluence in MSCBM
and then treated with trypsin-EDTA to remove them from the
culture dish. A portion of the cells were incubated with trypan
blue and counted using a Cellometer Auto T4 cell counter
(Nexcelom Bioscience LLC, Lawrence, MA) to determine the
number  of  viable  cells.  Wounded  corneas  were  placed
endothelial-side up on top of a Costar 12 mm Snapwell insert
with a 0.4 μm membrane (Sigma-Aldrich). The base of the
corneas was placed in MSCBM. An average of 5×105 viable
MSCs per 400 μl volume were then added to the endothelial
surface  in  two  applications.  First,  200  μl  of  cells  were
carefully added to the endothelial side of each cornea and the
corneas incubated at 37 °C for 1 h to permit the MSCs to settle
onto  the  wounded  endothelial  surface.  At  the  end  of  the
incubation period, the medium was gently removed from the
corneal cup, the 200 μl containing the remaining cells was
added, and the corneas then incubated overnight at 37 °C in a
humidified  atmosphere  in  the  presence  of  5%  CO2.  The
following morning, the corneas were removed from the insert
and  gently  placed  in  conventional  tissue  culture  wells
containing the desired culture medium and incubated at 37 °C.
Medium was changed 3 times per week and corneas were
incubated  for  14  days  before  processing  for
immunocytochemistry (see below). Cuts were made in the
sclera for orientation of the tissue at the end of the experiment.
Preparation  of  lens  epithelial  cell-conditioned  medium:
SV-40 transformed human lens epithelial cells were obtained
from  the  American  Type  Culture  Collection  (ATCC)  and
cultured  in  growth  medium  containing  ATCC-formulated
Eagle’s Minimal Essential Medium, 20% FBS, and antibiotic/
antimycotic solution diluted 1:100. This medium formulation
was designated for these studies as lens epithelial cell basal
medium (LECBM). Prior to use, a western blot analysis was
performed (data not shown) to verify the identification of
these cells by testing their ability to synthesize β- and γ-
TABLE 1. PRIMERS USED FOR REAL TIME RT–PCR.
Target Genes Sequence Product Size (bp)
NCAM1 F: 5′-GACTGTCACTCATTCTCCGATCAG-3′ 82
  R: 5′-GTATGATTATTTTTGCAGAATTGTTTCC-3′  
TFAP2B F: 5′-TTGGGTACATTTGCGAAACG-3′ 68
  R: 5′-TGTGTGCTGCCGGTTCAA-3′  
CDK15 F: 5′-CACCCAGCCCAGTTTAGCAA-3′ 73
  R: 5′-AAATACAGCCCTGGAAGAACCTT-3′  
MEIS1 F: 5′-GACAACCTCGCCTGTGATTGA-3′ 70
  R: 5′-CCCCTCAGACCCAACTACCA-3′  
COL8A1 F: 5′-GGAGATGCCCCACTTGCA-3′ 72
  R: 5′-GCCGGTTGAATTTCCTTCATAT-3′  
THY-1 F: 5′-ACCTCTTCCTCTTCCCTGACTTC-3′ 78
  R: 5′-GCCCAGTGTGCAGTCATTAGC-3′  
CDH2 F: 5′-GAGCAGTGAGCCTGCAGATTTT-3′ 81
  R: 5′-TGCTCAGAAGAGAGTGGAAAGCT-3′  
TJP1 F: 5′-AAAGGAGAGGTGTTCCGTGTTG-3′ 98
  R: 5′-CGTTCTACCTCCTTATGATTTTTACCA-3  
GAPDH F: 5′-GTATCGTGGAAGGACTCATGACCA-3′ 126
  R: 5′-TAGAGGCAGGGATGATGTTCTGGA-3′  
The primers were designed with Primer Express 1.5a software (Applied Biosystems). F: forward primer, R: reverse primer.
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550crystallins, as indicated by the ATCC. Cells were grown to
confluence in LECBM. Medium was changed twice a week.
At each medium change, the spent medium was collected,
centrifuged to remove cells and debris, and the supernatant
refrigerated until use. This medium was designated as lens
epithelial  cell-conditioned  medium  (LECCM).  In  all
experiments,  this  conditioned  medium  was  diluted  1:1  in
LECBM before use.
Immunocytochemical  localization:  Immunocytochemical
localization studies were conducted according to previously
published methods [40]. Briefly, samples were washed in
phosphate-buffered saline (PBS), fixed for 10 min in 100%
methanol at −20 °C, washed in PBS, and then incubated for
10 min in blocking buffer consisting of 4% BSA diluted in
PBS. Samples were then incubated overnight at 4 °C in rabbit
polyclonal  anti-ZO1  (Invitrogen)  diluted  1:150  and/or  in
mouse  monoclonal  anti-N-cadherin  (BD  Transduction
Laboratories, San Diego, CA) diluted 1:50. After washing,
samples  were  incubated  for  1  h  in  rhodamine-conjugated
donkey anti-rabbit IgG and/or in FITC-conjugated donkey
anti-mouse  IgG  (Jackson  ImmunoResearch  Laboratories,
West Grove, PA) diluted 1:100. All antibodies were diluted
in  blocking  buffer.  To  visualize  all  nuclei,  samples  were
incubated for 15 min at room temperature in iodide (TO-
PRO3: Invitrogen) diluted 1:1,000 in PBS. Negative controls
consisted of samples incubated in secondary antibody only.
Following washing, corneas were placed endothelial-side up
in  tissue  mounting  medium  (Vectashield:  Vector
Laboratories,  Burlingame,  CA)  and  covered  with  glass
coverslips. Cultured UCB MSCs were mounted in the same
medium  before  addition  of  glass  coverslips.  Fluorescence
staining  was  visualized  using  a  Leica  TSC-SP2  confocal
microscope (Bannockburn, IL). A Z-series was captured with
a step size of 0.5 μm per image. Z-series images were then
collapsed onto a single image plane by projecting the maximal
pixel intensity of the images. Each experiment was conducted
2–3 times to test for consistency of the results.
RESULTS
Morphological characteristics of two UCB MSC populations:
Two different populations of UCB MSCs, designated UCB1
and UCB4, were used in the initial stages of these studies.
Both UCB1 and UCB4 MSCs were grown in MSCBM until
cells covered the tissue culture dish. As can be seen by the
phase-contrast  images  in  Figure  1,  both  types  of  MSCs
exhibited a generally spindle-shaped morphology; however,
UCB1 cells were more elongated and fibroblast-like, while
UCB4 cells were larger and more flattened. At high density,
UCB1 cells were relatively closely associated and made a
swirl-like pattern of overlapping cells, whereas, UCB4 cells
grew in focal patches.
Comparison of gene expression in UCB MSCs and HCEC:
Microarray analysis was used to compare gene expression
between MSCs and HCEC. The cluster dendrogram in Figure
2A indicates relative similarity in gene expression among
closely  related  groups,  i.e.,  among  young  HCEC,  older
HCEC, UCB1, and UCB4 samples. As expected, relative gene
expression in both sets of HCEC samples exhibited closer
similarity to each other than to the two sets of UCB samples.
The same is true of the two types of UCB samples versus
HCEC. Significance Analysis of Microarrays (SAM) [41] was
conducted  to  compare  relative  gene  expression  between
UCB1 and UCB4 MSCs, each from two different passages
(UCB1P6, UCB1P8, UCB4P4, and UCB4P9) and passage 2
HCECs isolated and cultured from three young (17, 26, and
29 years old) and three older donors (50, 51, and 56 years old).
This comparison was made to establish a baseline of relative
gene  expression  for  UCB  MSCs  and  HCECs  before
attempting to differentiate MSCs toward more HCEC-like
cells. A list of the top 250 genes in which the mean expression
level in UCB MSCs is significantly higher than in HCEC is
presented in Appendix 1. Appendix 2 contains a list of the top
250 genes in which the mean expression level in UCB MSCs
is significantly lower than in HCEC. Figure 2B presents a heat
map comparing the relative expression of individual genes at
an  ANOVA  p-value  of  0.001.  The  heat  map  indicates
significant differences in the relative level of individual gene
expression among the UCB1, UCB4, young HCEC, and older
HCEC samples. In general, UCB samples exhibited greater
similarity in expression to each other than to either group of
HCEC and vice versa.
Quantitative real time-PCR studies were then conducted
using RNA isolated from the same UCB MSC and HCEC
samples to verify results of the microarray analysis for a subset
of genes. For these studies, data was averaged and comparison
was made between UCB1 MSCs, UCB4 MSCs, and HCECs
from both young and older donors (Figure 3). As observed in
the  microarray  analysis,  HCECs  expressed  significantly
higher mRNA levels of both NCAM1 (neural cell adhesion
molecule-1) and TFAP2B (transcription factor AP-2, beta)
compared with either type of MSC. Both UCB1 and UCB4
MSCs  expressed  significantly  higher  mRNA  levels  of
CDK15  (cyclin-dependent  kinase-15)  and  MEIS1  (Meis
homeobox1), as indicated by the microarray analysis. The
relative expression of four additional mRNAs was tested.
COL8A1  (collagen  VIII,  alpha-1)  is  expressed  in  corneal
endothelial cells [42], as well as in UCB1 MSCs [37]. Results
from qPCR indicated that, although all samples were positive,
UCB1 MSCs expressed relatively low, but detectable, levels
of COL8A1 in comparison with either UCB4 or HCECs. The
cell surface antigen, THY1 (CD90), is an important marker of
non-hematopoeitic UCB MSCs [37,43]. The qPCR results
indicated that THY1 mRNA is not only expressed in UCB1
and  UCB4  MSCs,  but  also  in  HCEC,  with  expression  in
HCEC  being  somewhat  lower  than  in  the  MSCs.  CDH2
(cadherin-2 / N-cadherin]) is expressed in corneal endothelial
cells [44]. Expression of this cadherin isoform has also been
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551detected  in  MSCs  [45].  Results  of  the  qPCR  showed  a
relatively similar level of N-cadherin mRNA expression in the
two UCB MSCs and HCEC samples. TJP1 (tight junction
protein-1 / ZO1) is expressed in corneal endothelial cells and
forms a discontinuous immunolocalization pattern at cell-cell
borders [46,47]. This protein has also been detected in MSCs
[45].  Comparisons  for  ZO1  mRNA  indicated  a  similar
expression in the two types of MSC samples tested, as well as
in HCECs.
Following these microarray and q-PCR analyses, it was
decided to use only UCB1 MSCs for subsequent studies. This
decision was based on the overall gene analysis results, which
showed somewhat closer gene expression levels in UCB1 to
HCECs compared with UCB4, and on the fact that previous
studies [37] suggested that UCB1 MSCs exhibit a greater
differentiation potential than UCB4 cells.
Effect of culture media on the morphology of UCB1 MSCs in
tissue  culture:  During  corneal  development,  appropriate
differentiation  of  neural  crest  mesenchymal  cells  to  form
corneal endothelium appears to be dependent on inductive
signals  from  the  lens  [20-25].  For  this  reason,  we  tested
whether soluble factors from cultured lens epithelial cells
would affect the differentiation of UCB1 MSCs toward more
HCEC-like  cells  using  lens  epithelial  cell-conditioned
medium (LECCM) prepared as indicated above. LECCM, the
basal  medium  used  for  growth  of  lens  epithelial  cells
(LECBM), and the basal medium used for culture of MSCs
(MSCBM)  were  first  compared  for  their  effect  on  the
morphology of UCB1 MSCs in culture. Crystal violet-stained
images of UCB1 MSCs grown in the 3 culture media are
shown in Figure 4. As described previously [37] and shown
in Figure 1A,C, UCB1 MSCs grown in MSCBM (Figure 4A)
exhibited elongated, fibroblastic-like shapes and tended to
Figure 1. Phase-contrast images of UCB1 and UCB4 MSCs. Note the more elongated shape and swirl pattern formed by UCB1 cells compared
with the broader shape of UCB4 cells growing in focal patches. UCB1 MSCs are passage 11. UCB4 MSCs are passage 3. Original magnification
of (A) and (B): 4×. Original magnification of (C) and (D): 10×.
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552form a swirl pattern with evidence of cellular overlap. MSCs
grown  in  LECBM  (Figure  4B)  also  exhibited  elongated,
fibroblastic-like shapes, but the cultures tended to have more
open areas between cell clusters where cells appeared to be
somewhat more broad and flattened. Cells within clusters
formed a random criss-cross pattern, indicating multiple cell
layers. UCB1 MSCs grown in LECCM (Figure 4C) were
consistently more highly elongated than cells grown in the
other two media. Cells in the more open areas of the culture
tended  to  form  parallel  arrays,  while  cells  located  within
clusters showed evidence of multi-layering.
Effect of culture media on junction formation in UCB1 MSCs
in tissue culture: Immunolocalization studies were conducted
to  determine  the  effect  of  the  three  culture  media  on  the
subcellular  localization  of  the  tight  junction-associated
protein, ZO1, and the adherens junction protein, N-cadherin,
since both these proteins are localized at cell-cell borders in
HCEC and help support the barrier function of these cells
[44,46]. For these studies, UCB1 MSCs were grown in each
of the three types of media until cells filled the culture dish
and then immunostained for both ZO1 and N-cadherin. Figure
5 presents images of the cells stained for either ZO1 or N-
cadherin alone to clearly show the staining pattern, as well as
the same images showing TO-PRO-3 staining to indicate the
presence of nuclei. Growth in MSCBM resulted in a generally
diffuse  cytoplasmic  localization  of  ZO1  (Figure  5A,D),
although a few intensely stained short, linear plaques could be
seen within the cytoplasm and, in some cells, these plaques
appeared to be localized to the lateral plasma membrane.
MSCs grown in LECBM (Figure 5B,E) exhibited a light,
diffuse cytoplasmic stain for ZO1, but under this medium
condition, the relative number and intensity of the short, linear
plaques  were  increased  at  cell  borders.  Growth  of  UCB1
MSCs in LECCM (Figure 5C,F) showed a similar increase of
the size and relative number of positive ZO1 plaques at cell
borders.  The  LECCM-induced  cellular  elongation  and
parallel  arrangement  were  easily  visualized  by  the  ZO1
immunostaining. As with ZO1, the staining pattern for N-
cadherin differed based on the growth medium. In UCB1
MSCs grown in MSCBM (Figure 5G,J), N-cadherin showed
mainly  a  diffuse  cytoplasmic  localization  with  occasional
linear staining at cell borders. Cells grown in LECBM (Figure
5H,K) showed light, diffuse cytoplasmic staining, but there
was also more intense staining in linear plaques at cell borders.
MSC  grown  in  LECCM  (Figure  5I,L)  showed  positive
staining for N-cadherin mainly along cell borders. Images in
Figure 5M,N show the negative controls for ZO1 and N-
cadherin, respectively, in which cells were only incubated in
the presence of secondary antibody. The lack of rhodamine or
FITC staining in these images indicates the overall specificity
of the staining results using primary antibody.
Overall, results indicated that both ZO1 and N-cadherin
proteins are expressed by UCB1 MSCs under each of the
culture medium conditions tested; however, the subcellular
localization  of  these  proteins  differed  with  the  specific
medium.  Cells  grown  in  the  presence  of  LECBM  and,
particularly in the presence of LECCM, showed increased
localization of both proteins at cell-cell borders, suggesting
Figure 2. Cluster dendrogram and heat map results. Cluster dendrogram (A) shows relationships in gene expression among UCB1, UCB4,
young HCEC, and older HCEC samples. The heatmap in (B) shows relative levels of gene expression at a p-value of 0.001 between UCB1
and UCB4 MSCs and HCECs from young and older donors. The relative levels of gene expression are depicted using a color scale where red
represents the lowest and green represents the highest level of expression.
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553Figure  3.  Quantitative  real-time  PCR
confirms differences in gene expression
identified  by  microarray  analysis  in
UCB1,  UCB4,  and  HCEC.  Relative
expression levels were normalized to the
housekeeping  gene  GAPDH  and  are
shown relative to the highest value (0 to
1).  Error  bars  represent  one  standard
deviation for the four UCB (two UCB1
and two UCB4) and six HCEC biologic
replicates  tested.  Robust  multi-array
average  (RMA)  estimated  expression
levels  from  the  Affymetrix  array,
averaged  for  the  biologic  replicates
within each cell type, are listed on the x-
axis.
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554the formation of tight and adherens junctions between cells.
Since the integrity of both tight [48] and adherens junctions
[49] is dependent on the presence of extracellular calcium, we
tested the effect of removal of extracellular calcium on the
morphology of UCB1 MSCs and the localization of ZO1 and
N-cadherin. For these studies, UCB1 MSC, grown in LECBM
or LECCM, were incubated in the presence and absence of a
5 mM concentration of the calcium chelator, ethylene glycol
tetraacetic acid (EGTA). The relative integrity of the resulting
cultures  was  examined  by  phase-contrast  microscopy.  As
shown in Figure 6, UCB1 MSCs grown in either LECBM or
LECCM and treated with EGTA showed large breaks within
the culture and areas where individual cells were located some
distance from each other. This pattern strongly suggested that
treatment with EGTA had caused the separation and loss of
cells within the culture. The effect of EGTA treatment on ZO1
and N-cadherin localization in cells grown in LECBM and
LECCM  was  determined  using  fluorescence  confocal
microscopy. Similar results were obtained with cells grown in
both  media.  Images  in  Figure  6  show  that  EGTA-treated
UCB1 MSCs grown in LECCM lost their highly elongated
shape and became separated from each other within the cell
sheet. The relative intensity of both ZO1 and N-cadherin in
the  EGTA-treated  cultures  was  greatly  reduced  compared
with untreated controls and the staining patterns changed from
the proteins being mainly localized to cell borders in non-
EGTA-treated cultures to being diffusely distributed within
the cytoplasm in cultures treated with EGTA. This change in
subcellular localization is consistent with the loss of cell-cell
junctions.
UCB MSCs attach to wounded endothelium in ex vivo cornea
models:  The  feasibility  of  using  UCB1  MSCs  to  replace
HCEC that have been lost due to mechanical trauma was
determined by testing the ability of these cells to “home” to
wounded corneal endothelium in donor human corneas. Two
types  of  ex  vivo  corneal  endothelial  wound  models  were
tested. These included a crush wound in which endothelial
cells were damaged with a capsule polisher and a scrape
wound in which endothelial cells were scraped off Descemet’s
membrane, but leaving Descemet’s membrane intact. After
wounding  of  the  endothelium,  green  fluorescent  protein
(GFP)-labeled UCB1 MSCs were seeded onto the endothelial
surface and then maintained in MSCBM. Ex vivo corneas
containing intact endothelium were used as controls. After 2
weeks  in  culture,  the  relative  attachment  of  GFP-labeled
UCB1  MSCs  was  evaluated  by  fluorescence  confocal
microscopy.  ZO1  immunostaining  was  used  to  identify
undamaged HCEC, because of its distinctive staining pattern
in  corneal  endothelium  [46,47].  Damaged  HCEC  were
identified by the presence of ZO1 staining, but loss of this
distinctive  pattern.  Nuclei  were  detected  by  TO-PRO-3
staining.  UCB1  MSCs  did  not  attach  to  undamaged
endothelium  (Figure  7A),  but  consistently  attached  to
damaged endothelium in both the crush wound (Figure 7B)
and  scrape  wound  models  (Figure  7C).  Relatively  little
attachment  of  UCB1  MSCs  to  denuded  Descemet’s
membrane was observed (Figure 7C). Overall, these results
indicate that UCB1 MSCs can participate in the healing of
corneal endothelial wounds by attaching to damaged HCEC
in ex vivo corneas. The crush wound model was chosen for
all  subsequent  ex  vivo  studies,  because  it  best  parallels
conditions  expected  for  the  healing  of  corneal  wounds
resulting from mechanical trauma.
Effect of culture media on UCB1 MSCs in the ex vivo crush
wound model: Studies were conducted to determine the effect
of the three culture media on association of non-GFP-labeled
UCB1 MSCs with damaged endothelium using the ex vivo
crush wound model. For these studies, crush wounds were
made in the endothelium of donor corneas. Corneas were
incubated for 48 h in MSCBM plus 30 µg/ml 5-fluorouracil
(5-FU)  to  inhibit  proliferation  of  the  HCEC  and  prevent
premature closure of the wounds. After washing to remove
the 5-FU, UCB1 MSCs were placed on the endothelial side of
the corneas and incubated for 2 weeks in the presence of
MSCBM, LECBM, or LECCM. Corneas were then processed
for ZO1 staining and nuclear labeling with TO-PRO-3. As can
Figure 4. Crystal violet-stained light microscopic images of UCB1 MSCs. Cells grown in MSC basal medium (MSCBM; A), lens epithelial
cell basal medium (LECBM; B), or lens epithelial cell-conditioned medium (LECCM; C) show relative differences in cell shape and culture
characteristics. Original magnification: 4×.
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555Figure 5. ZO1 (red) and N-cadherin (green) staining patterns in UCB1 MSCs incubated in three different culture media. Images in A-C show
ZO1 staining alone, while images D-F show an overlay of the ZO1 and TO-PRO-3 (blue) staining, so individual cells can be observed. Images
G-I show N-cadherin staining alone, while images J-L show an overlay of the N-cadherin and TO-PRO-3 staining. Images M and N are
negative controls showing overlays of the rhodamine and TO-PRO-3 channels (M), and FITC and TO-PRO-3 channels (N). Original
magnification: 40×.
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556Figure 6. Effect of EGTA treatment on UCB1 MSC morphology and junction-associated protein localization. Top four phase-contrast images
demonstrate that EGTA treatment induces separation of UCB1 MSCs in cultures grown in either lens epithelial cell basal medium (LECBM)
or lens epithelial cell-conditioned medium (LECCM). Arrows in the (+) EGTA images indicate large spaces between cells. Confocal
fluorescence images at the bottom demonstrate changes in the relative localization of N-cadherin (FITC) and ZO1 (rhodamine) in UCB1
MSCs grown in LECCM. Both bottom images are overlays with TO-PRO-3 (blue) to visualize nuclei. Phase contrast original magnification:
4×. Confocal original magnification: 40×.
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557be seen in Figure 8, UCB1 MSCs associated with damaged
HCEC regardless of the culture medium used. However, there
was a consistent difference noted in the relative arrangement
of the cells based on the culture medium. In the presence of
MSCBM (Figure 8A,D), MSCs showed a relatively random
orientation within the damaged areas, whereas, when MSCs
were incubated in LECBM (Figure 8B,E) or LECCM (Figure
8C,F), the MSCs tended to form a more oriented and more
tightly associated cell sheet in the wound area.
Experiments were then conducted to determine the effect
of the three culture media on the localization of ZO1 and N-
cadherin when UCB1 MSCs were added to ex vivo corneal
endothelial crush wounds. A similar protocol was used for
these studies as for the ex vivo studies discussed above. The
only difference was that the tissue was processed for both ZO1
and N-cadherin immunostaining. Images in Figure 9 show that
both ZO1 and N-cadherin were expressed under all 3 medium
conditions; however, as observed in the tissue culture studies,
the relative localization of both proteins differed depending
on the culture medium. In UCB1 MSCs incubated in MSCBM
(Figure  9A,D),  ZO1  and  N-cadherin  were  both  diffusely
distributed  within  the  cytoplasm.  Both  proteins  showed  a
greater  association  with  cell  borders  when  MSCs  were
incubated  in  LECBM  (Figure  9B,E),  but  the  overall
arrangement  of  the  cells  was  relatively  random.  MSCs
incubated  in  LECCM  (Figure  9C,F)  showed  the  greatest
association of both ZO1 and N-cadherin at cell borders. Cells
also formed a relatively tight sheet of parallel cells within the
wound area.
Effect of culture media on relative gene expression of UCB1
MSCs: Of the several culture media tested using either the
tissue culture or ex vivo crush wound models, it was clear that
LECCM had the greatest influence on the phenotype of UCB1
MSCs. Because of these changes, it was decided to compare
the effect of LECBM and LECCM on relative gene expression
in UCB1 MSCs. For these studies, UCB1 MSCs were cultured
in the presence of LECBM or LECCM until the cells filled the
culture dish. Cells were then washed and RNA was extracted
and purified as previously. A second round of microarray
analyses was conducted similar to those described above.
Careful analysis indicated several differences in relative gene
expression. Of the 250 genes that were expressed at higher
levels when UCB1 MSCs were grown in LECCM compared
with LECBM (Appendix 3), 18 were also expressed at higher
levels in HCEC compared with either UCB1 or UCB4 MSCs
(compare  with  Appendix  2).  These  genes  included  C3
(complement  component  3),  IL8  (interleukin  8),  PTGS2
(prostaglandin-endoperoxide  synthase  2,  also  called
prostaglandin G/H synthase and cyclooxygenase), RAB27B
(RAB27B,  member  RAS  oncogene  family),  CXCL1
(chemokine  (C-X-C  motif)  ligand  1  (melanoma  growth
stimulating  activity,  alpha),  IL13RA2  (interleukin  13
receptor, alpha 2), TFPI2 (tissue factor pathway inhibitor 2),
PLA2G4A  (phospholipase  A2,  group  IVA  (cytosolic,
calcium-dependent),  STC1  (stanniocalcin  1),  DPP4
(dipeptidyl-peptidase  4),  GDF15  (growth  differentiation
factor 15), AKR1C1 (aldo-keto reductase family 1, member
C1  (dihydrodiol  dehydrogenase  1;  20-alpha  (3-alpha)-
hydroxysteroid  dehydrogenase),  DNER  (delta/notch-like
EGF  repeat  containing),  SAT1  (spermidine/spermine  N1-
acetyltransferase 1), DUSP6 (dual specificity phosphatase 6),
MTHFD2L  (methylenetetrahydrofolate  dehydrogenase
(NADP+  dependent)  2-like),  MANSC1  (MANSC  domain
containing  1),  and  RNY5  (RNA,  Ro-associated  Y5).
Together,  this  data  indicates  a  change  in  the  relative
expression  of  a  subset  of  genes  based  on  incubation  in
LECCM and differentiation of UCB1 MSCs toward a more
HCEC-like phenotype.
Figure 7. Attachment of GFP-labeled UCB1 MSCs to damaged endothelium. The image in (A) shows lack of attachment of UCB1 MSCs to
unwounded endothelium. The inset shows results of the no-primary negative control for ZO1 staining. GFP-labeled UCB1 MSCs in (B)
attached to damaged endothelium in the crush wound model. Arrowheads indicate the ZO1 pattern of unwounded HCEC. The image in (C)
shows attachment of GFP-labeled UCB1 MSCs to remnants of damaged endothelium in the scrape wound model. Arrows indicate areas of
damaged HCEC. Red: ZO1. Blue: TO-PRO-3-stained nuclei. Blue: TO-PRO-3-stained nuclei. Original magnification: 40×.
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Several studies have reported the usefulness of mesenchymal
stem cells for the treatment of corneal diseases. For example,
UCB  MSCs  have  been  transplanted  into  the  corneas  of
lumican null mice [50]. This treatment significantly improved
corneal transparency and increased stromal thickness. There
is  also  a  report  of  the  successful  use  of  autologous  bone
marrow MSCs as a means of replacing corneal endothelium
in rabbits in vivo [51].
Although UCB MSCs and HCECs are clearly different
cell types, they share several important mesenchymal cell
characteristics.  The  basic  hypothesis  driving  the  current
studies was that it should be possible to modify the phenotype
of UCB MSCs so that they could function as HCECs. As a
first step in testing this hypothesis, the current in vitro studies
tested the feasibility of altering the phenotype of UCB MSCs
toward that of HCEC-like cells and investigated whether UCB
MSCs can “home” to sites of corneal endothelial cell injury.
In these studies, two different clones of UCB MSCs were
initially  examined.  The  first  series  of  microarray  data
established a baseline of relative gene expression between
MSCs  and  HCEC  that  could  be  used  for  subsequent
comparison following attempts to differentiate UCB MSCs
toward HCEC-like cells. As expected, the results showed that
UCB1 and UCB4 MSCs exhibit close, but not identical gene
expression patterns. Both MSC clones showed a closer gene
expression profile to each other than to HCEC. Similarly, the
profiles of HCECs from young and older donors were closer
to each other than to either of the MSC clones. The analysis
also  identified  certain  genes  that  may  act  as  markers  to
distinguish between these two cell types and provide evidence
of differentiation of MSCs toward HCEC-like cells. Although
expression of only a small subset of genes was verified by q-
PCR, the results paralleled the findings of the microarray
analysis. As indicated above, the choice of UCB1 MSCs for
further study was based on information indicating that this
clone displayed greater overall differentiation potential [37].
In fact, our previous studies confirm that these cells behave
as precursors, recapitulating basic developmental pathways
when assayed at the molecular level and used as an in vitro
model for somitogenesis, a basic process in musculoskeletal
development [52].
In vivo, cell shape and the ability of cells to maintain
corneal transparency are major criteria for identification of
healthy corneal endothelium. Because authentic phenotypic
Figure 8. Effect of 3 culture media on UCB1 MSC association with damaged endothelium. Fluorescence confocal microscopic images show
the formation of MSC cell sheets in areas of damaged HCEC (arrows in A-C). Note that, in wounded corneas incubated in MSCBM, ZO1 is
localized diffusely within the cytoplasm of the MSCs. In wounded corneas incubated in LECBM or LECCM, ZO1 tended to be localized at
the lateral borders of MSCs. Red: ZO1. Blue: TO-PRO-3-stained nuclei. Original magnification: 40×.
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559markers  for  HCEC  have  not  been  identified,  in  vitro
identification  of  these  cells  can  be  problematic.  For  this
reason, a combination of criteria is generally used for cell
identification. These include cell shape, the expression and
appropriate  localization  of  proteins  known  to  support  the
barrier  and  pump  functions  of  these  cells,  as  well  as  the
expression  of  proteins  that  help  distinguish  HCEC  from
corneal keratocytes and epithelial cells. In the current studies,
several approaches were used to initially compare HCEC and
UCB MSCs and to follow phenotypic changes in UCB MSCs
that would suggest their alteration to more HCEC-like cells.
Differentiation  of  MSCs  along  specific  lineages  is
dependent, at least in part, on microenvironmental conditions
[45,53].  In  these  studies,  lens  epithelial  cell-conditioned
medium (LECCM) was used as a means of mimicking the
effect of the lens during corneal endothelial differentiation
from neural crest mesenchymal cells. A major effect of this
medium was the consistent elongation of the UCB1 MSCs,
both in tissue culture and in the ex vivo crush wound model.
This change in cell shape did not occur as consistently or to
the same extent when cells were exposed to the basal medium
used to culture the lens epithelial cells (LECBM). Overall,
these results suggest that the shape of UCB1 MSCs can be
altered  based  on  culture  medium  composition  and  that
medium conditioned by lens epithelial cells contains one or
more factors that enhance the elongation of UCB1 MSCs. The
specific factor(s) in the medium that induce this change were
not identified in these studies. Of interest is the fact that the
shape of UCB MSCs, when incubated in LECCM, was similar
to that of lens fiber cells. The original microarray analysis
conducted in this study indicates a very similar expression of
both αA- and αB-crystalline genes in UCB1 MSCs and in
HCECs (data not shown), and there was no significant change
in  the  level  of  either  of  these  genes  when  MSCs  were
incubated  in  LECCM.  As  such,  at  least  at  this  level  of
investigation, there is no strong evidence that MSCs were
altered  to  lens  fiber-like  cells  upon  LECCM  incubation;
however, it would be important to thoroughly test for this
possibility in future studies.
It is unclear from the current studies whether the shape
of UCB1 MSCs could be modified to more closely resemble
that of HCEC. Of interest is the fact that several investigators
have observed that HCEC can change from the characteristic
flattened,  hexagonal  shape  to  that  of  elongated,  more
Figure 9. Effect of 3 culture media on ZO1 and N-cadherin localization in MSCs associated with damaged HCEC. Fluorescence confocal
microscopic images show that, in wounded corneas incubated in MSCBM, ZO1 and N-cadherin were localized diffusely within the cytoplasm
of the MSCs. In wounded corneas incubated in LECBM or LECCM, ZO1 and N-cadherin tended to localize at the lateral borders of MSCs.
Arrows in A-C show edges of the damaged endothelium. Red: ZO1. Green: N-cadherin. Original magnification: 40×.
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560fibroblast-looking  cells  [54-59].  These  alterations  in  cell
shape appear to be due to a form of endothelial-mesenchymal
transition  mediated  by  environmental  factors  such  as
extracellular matrix composition and specific growth factors.
Since endothelial cells themselves can change to an elongated,
fibroblastic shape, the use of shape for the identification of
HCEC-like  cells  in  these  studies  was  problematic.  The
original elongated shape of UCB MSCs in their basal medium
(MSCBM)  was  enhanced  by  incubation  in  LECBM,  and
particularly  in  LECCM.  The  specific  intracellular  signals
leading to this morphologic change are not known and the
scope of the current study did not permit investigation of
whether the shape of UCB MSCs could be altered to more
closely resemble that of HCEC. Further investigation of the
molecular basis of the epithelial-to-mesenchymal transition in
HCEC  may  provide  information  important  to  stimulate  a
mesenchymal-to-epithelial transition of UCB MSCs.
Studies of human bone marrow-derived MSCs [45] have
demonstrated the formation of calcium-dependent junctional
complexes containing several adhesion-associated proteins,
including N-cadherin and ZO1. Since the barrier function of
HCEC is dependent, at least in part, on the formation of N-
cadherin-containing adhesion junctions [44], as well as on
ZO1-associated tight junctions [46], it was important to test
their relative expression and subcellular localization in UCB
MSCs incubated under different conditions. Microarray and
q-PCR analyses indicated that both HCEC and UCB MSCs
express  N-cadherin  and  ZO1  at  relatively  similar  levels.
Importantly,  the  immunolocalization  studies  provided
evidence of medium-dependent changes in the localization of
these proteins in UCB1 MSCs in both the tissue culture and
ex vivo corneal endothelial crush wound models. For these
studies, the lack of staining in the negative controls indicated
the overall specificity of the results. The primary antibodies
used did not specifically distinguish between the cytoplasmic
(newly synthesized) and plasma membrane (functional) forms
of these proteins, therefore, the localization of both proteins
to the cytoplasm, particularly in cells incubated in MSCBM,
suggests that the proteins were being synthesized under these
conditions,  but  not  transported  to  the  plasma  membrane.
Incubation in LECBM, and particularly LECCM, resulted in
greater localization of both proteins to the plasma membrane.
The fact that EGTA treatment increased spaces between the
cells and caused a change in localization of both ZO1 and N-
cadherin from cell borders to a diffuse distribution within the
cytoplasm  strongly  suggests  that  true,  calcium-dependent
junctions were formed when cells were grown in LECBM and
LECCM. The consistent movement of both these proteins to
the plasma membrane, particularly in UCB1 MSCs grown in
LECCM,  indicates  the  induction  of  an  important  change
toward HCEC-like cells. The molecular basis for this change
is not known and should be investigated in future studies. One
of the major differences between MSCBM and LECBM is an
increase in FBS concentration from 10% to 20%. Although
the effect of these media on cell proliferation was not directly
determined in this study, the increase in FBS concentration
may be responsible for an overall increase in cell density,
thereby  promoting  formation  of  both  tight  and  adherens
junctions between the more closely-packed neighboring cells.
Of significance was the consistent observation that UCB1
MSCs attached with great efficiency to wounded HCEC, but
did not adhere strongly to either unwounded endothelium or
to Descemets’ membrane that had been scraped to remove
HCEC. This tendency of MSC to “home” to wound areas has
been observed previously [60-62] and would be important in
the treatment of corneal endothelial injuries. Of the three
culture media tested, LECCM appeared to promote the closest
cell-cell association and, in the ex vivo crush wound model,
yielded an apparent monolayer of closely-packed, elongated
cells.  Incubation  in  LECCM  also  appeared  to  alter  the
expression of several genes in UCB MSCs to more closely
resemble that of HCEC. Although LECCM appeared to have
the greatest effect on the UCB MSC phenotype, it did not
produce optimal results, indicating the need for additional
study  to  identify  the  specific  microenvironmental  factors
needed to consistently alter the phenotype of UCB MSCs to
that of HCEC-like cells.
Overall, results of these studies strongly indicate that
UCB MSCs can “home” to areas of corneal endothelial cell
injury, as well as demonstrate the feasibility of altering the
phenotype of UCB MSCs toward that of HCEC-like cells.
Additional studies, including in vivo testing, are now needed
to identify the specific conditions that would best support the
ability of UCB MSCs to replace corneal endothelial cells lost
due to damage or disease as a means of restoring corneal
transparency.
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563Appendix 1
Appendix 1. Four microarray/ human gene expression
studies:  housekeeping  and  non-housekeeping  genes
expressed.  To  access  the  data,  click  or  select  the  words
“Appendix 1.” This will initiate the download of a compressed
(pdf) archive that contains the file.
Appendix 2
Appendix 2. Non-HK TM genes with altered expression
due  to  glaucoma  relevant  exprimental  manipulations.  To
access the data, click or select the words “Appendix 2.” This
will initiate the download of a compressed (pdf) archive that
contains the file.
Appendix 3
Appendix  3.  Non-HK  human  TM  expressed  genes
grouped based on function. To access the data, click or select
the words “Appendix 3.” This will initiate the download of a
compressed (pdf) archive that contains the file.
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